Showing results (1-10 of 273) with videos related to
Sort By:
Pageof 28
Headache|July 16, 2013
Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of developmentMarcelo E Bigal, Sarah Walter, Alan M RapoportBritish Journal of Clinical Pharmacology|January 24, 2015
Therapeutic antibodies against CGRP or its receptorMarcelo E Bigal, Sarah Walter, Alan M RapoportExpert Review of Neurotherapeutics|May 3, 2019
Fremanezumab as a preventive treatment for episodic and chronic migraineMarcelo E Bigal, Sarah Walter, Alan M RapoportComprehensive Therapy|April 19, 2003
The clinical spectrum of migraineAlan M Rapoport, Marcelo E BigalCurrent Pain and Headache Reports|November 15, 2011
Obesity and chronic daily headacheMarcelo E Bigal, Alan M RapoportCurrent Pain and Headache Reports|November 1, 2008
Advances in the pharmacologic treatment of tension-type headacheMarcelo E Bigal, Alan M Rapoport, Richard HargreavesCNS Drugs|October 13, 2018
From LBR-101 to Fremanezumab for MigraineMarcelo E Bigal, Alan M Rapoport, Stephen D Silberstein, et al.CNS Drugs|March 19, 2014
Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activityMarcelo E Bigal, Sarah WalterCurrent Pain and Headache Reports|March 11, 2015
TEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraineSarah Walter, Marcelo E BigalExpert Opinion on Pharmacotherapy|April 2, 2003
New developments in migraine prophylaxisMarcelo E Bigal, Abouch V Krymchantowski, Alan M RapoportPageof 28